Postoperative Residual Weakness
1 clinical trials · Condition
◉ Watch Postoperative Residual Weakness
| Record | Firm | Date |
|---|---|---|
| Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade at the End of Kidney Transplantation Surgery (NCT03923556) | University of Colorado, Denver | 2021-02-02 |
Track Postoperative Residual Weakness automatically
Every clearance here is in the API, with alerts when new ones post.